AAC Generative Language Intervention for Speech Disorders
(MALD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach to help people with speech disorders communicate better using a method called AAC Generative Language Intervention. It focuses on improving communication for individuals with Down syndrome or cerebral palsy who have significant speech impairments. Participants must express at least 25 words, use an iPad communication app accurately, and have functional vision and hearing. The trial aims to make communication easier and more effective for those who struggle with speech. As an unphased trial, it offers participants the chance to contribute to innovative research that could significantly enhance communication methods for those with speech disorders.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this intervention is safe for speech disorders?
Earlier research has studied similar communication aids, with few reports of negative effects. This suggests these treatments are generally well-tolerated. AAC helps people with speech difficulties communicate better, often using symbols or devices to form words and sentences. Although specific safety data for the AAC Generative Language Intervention is not yet available, existing evidence from other AAC treatments shows they are safe to use.12345
Why are researchers excited about this trial?
Researchers are excited about the AAC Generative Language Intervention because it offers a novel approach for treating speech disorders, particularly for individuals who rely on augmentative and alternative communication (AAC) systems. Unlike traditional speech therapy methods that primarily focus on repetitive practice and structured exercises, this intervention uses generative language techniques to enhance spontaneous and creative language use. This approach has the potential to improve communication effectiveness and engagement by encouraging more natural language development, which is a significant shift from conventional therapies.
What evidence suggests that AAC Generative Language Intervention might be an effective treatment for speech disorders?
Research shows that the AAC Generative Language Intervention, provided to participants in this trial, can aid in treating speech disorders. One study with individuals who have apraxia of speech and aphasia demonstrated significant improvements in word accuracy after a 4-week therapy program. Additionally, research indicates that 75-85% of AAC users experience major improvements in self-expression and communication. This treatment may also benefit individuals with conditions like Alzheimer's, Parkinson's, and autism by enhancing their communication skills. Overall, AAC interventions have a strong history of improving language abilities.16789
Are You a Good Fit for This Trial?
This trial is for English-speaking individuals with Down Syndrome or Cerebral Palsy who have significant speech impairments. Participants should be able to express at least 25 words in any communication mode and select picture symbols on an iPad app with over 50% accuracy, provided their vision and hearing are within functional limits.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive aided language intervention to measure language development
Follow-up
Participants are monitored for language development and effectiveness after intervention
What Are the Treatments Tested in This Trial?
Interventions
- AAC Generative Language Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Central Florida
Lead Sponsor
University of New Mexico
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
University of Wisconsin, Milwaukee
Collaborator